Thomas Seyfried

Thomas N. Seyfried works at Boston College. He reads Warburg as a mill question: some growth prefers sugar and will not use fat the way a healthy cell can. That is Current #27, spoken in a tumor’s language. It is not a cancer protocol. It is not a keto product. It is not MEGA-ATP.

He sat on the same OMNS wall as Michael J. Gonzalez. He spoke in Istanbul in 2026. This page honors the fuel question. The chair next door stays. Do not stop licensed oncology because a mouse study got loud.

If a cell can use more than one fuel, a cell that cannot is weather. Eat is still the plate. Glucose is not the enemy of a person who is well. The five are still the day. Florida will name flexibility again under load. This page only names the question.

Keep Eat. Keep Correction. If a question is a tumor in your own body, take it to someone licensed who knows that chair. Richard Z. Cheng is next — the page that kept this room speaking.

You are not behind if you never read a Boston College paper. You are not too late. Your mills are still minting every second of every day. Feed them. The tumor-fuel question is a layer. It is not Tuesday.

Will you treat tumor fuel as a mill question — and still keep Eat as the day? The answer is yours. You can take it. You can leave it. No one can take it for you.

If you take it, eat tonight. That is Seyfried, kept as literacy — not as a protocol.

If you want to keep learning, keep flowing with our Currents. Richard Z. Cheng is next.